Background Ozanimod, a sphingosine 1-phosphate receptor modulator, selectively binds to
receptor subtypes 1 and 5 with high affinity. The RADIANCE phase 2 study showed that …

Background Ozanimod is a sphingosine 1-phosphate receptor modulator, which selectively
binds to sphingosine 1-phosphate receptor subtypes 1 and 5 with high affinity. In the …

Knowledge management (KM) research has been evolving for more than a decade, yet little
is known about KM theoretical perspectives, research paradigms, and research methods. …

Background: Ozanimod, an oral sphingosine 1-phosphate receptor 1 and 5 modulator, is
approved in multiple countries for treatment of relapsing forms of MS. Objective: To …

The events of September 11, 2001 forever changed policing with state and local law
enforcement now playing a central role. In this new role many agencies have begun to re‐assess …

Purpose – The purpose of this paper is to reduce ambiguity in diverse approaches to health
knowledge management by surfacing key issues, perspectives and philosophical …

Accumulating evidence from human-based research has highlighted that the prevalent one-size-fits-all
approach for neural and behavioral interventions is inefficient. This approach can …

Motor overflow is an unintentional muscle contraction which accompanies, but is anatomically
distinct from the primary dystonic movement. This phenomenological nosology has not …

Background Cognitive dysfunction, including slowed cognitive processing speed (CPS), is
one of the most disabling symptoms of multiple sclerosis (MS). The Symbol Digit Modalities …

Aim: Ozanimod and fingolimod are sphingosine 1-phosphate receptor–modulating therapies
for relapsing multiple sclerosis. Patients & methods: Comparative effectiveness was …